DXB 1.28% 38.5¢ dimerix limited

Ann: Dimerix Successfully Passes Efficacy Interim Analysis, page-68

  1. 22 Posts.
    lightbulb Created with Sketch. 2
    Hi all,

    This may be useful for those who questioned why detailed interim results were not released to the public.

    Guidance on interim analysis methods in clinical trials

    https://hotcopper.com.au/data/attachments/6023/6023839-59405b147abb5fe0edf147033a37bf17.jpg
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.